Dwight Moxie Net Worth & Insider Trades

Dwight Moxie - SVP, Revance Therapeutics, Inc

As of September 16, 2022

What is Dwight Moxie's Net Worth?

The current estimated net worth of Revance Therapeutics, Inc's SVP, Dwight Moxie, is estimated to be about $1M . Dwight Moxie owns about 31,694 units of Revance Therapeutics, Inc common stock. In the last 2 years at Revance Therapeutics, Inc, Dwight Moxie has sold an estimated value of $615.12K worth.

What is Dwight Moxie's Past Insider Trading?

Dwight Moxie's largest sale order was 11,000 units , worth over $297.8K on September 16, 2022. In total, Dwight Moxie has made about 8 transactions over 2 years of their time at Revance Therapeutics, Inc. Dwight Moxie usually trades in February, with the busiest year in 2022 and 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Dwight Moxie's Salary in 2020?

As SVP of Revance Therapeutics, Inc, Dwight Moxie has a total base salary of $370,104 . Dwight Moxie received compensation valued at about $4,519,508 in 2020 after becoming SVP. The vast majority of their compensation came in the form of a bonus of $125,000 , stock awards of $1,309,383 , option awards of $2,579,240 , other earnings, plans or compensations of $125,426 , and other compensation of $10,356 .

What is Dwight Moxie's' Mailing Address?

  • Mailing address is 7555 Gateway Boulevard Newark CA 94560 CA

Revance Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark J. Foley 2020 $650,000 - $7,794,350 - $328,331 $8,255 $8,780,936
Mark J. Foley 2019 $189,764 $150,000 $11,728,370 $5,112,573 - $9,723 $17,190,430
Tobin C. Schilke 2020 $421,375 - $1,131,345 $1,273,662 $143,186 $11,531 $2,981,099
Tobin C. Schilke 2019 $407,126 $25,000 $86,150 $299,781 $178,123 $11,078 $1,007,258
Tobin C. Schilke 2018 $64,644 $25,000 $449,280 $1,434,350 - $233 $1,973,507
Abhay Joshi, Ph.D. 2020 $514,608 - $1,405,850 $1,913,759 $213,726 $11,731 $4,059,674
Abhay Joshi, Ph.D. 2019 $485,479 - $271,373 $939,314 $204,211 $9,520 $1,909,897
Abhay Joshi, Ph.D. 2018 $469,062 - $342,513 $1,192,465 $232,186 $9,210 $2,245,436
Dustin Sjuts 2020 $415,000 - $1,294,250 $1,306,320 $141,020 $66,242 $3,222,832
Dustin Sjuts 2019 $378,333 $50,000 $43,075 $99,927 $183,902 $45,786 $801,023
Dwight Moxie 2020 $370,104 $125,000 $1,309,383 $2,579,240 $125,426 $10,356 $4,519,508
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1479290/000147929021000089/rvncfy20proxystatementdef1.htm

What are Revance Therapeutics, Inc's Past Insider Trades?

Revance Therapeutics, Inc's most recent insider trade came on January 23, 2023 by Tobin Schilke who sold 1,000 units worth $31K . In the last 9 years, insiders at Revance Therapeutics, Inc have sold an estimated value of $31.65M and bought an estimated value of $8.66M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Daniel Browne, CEO and President,  Curtis Ruegg, EVP,  and Lauren Silvernail, CFO & CBO .

Revance Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1